Home » Topics » Conferences

Conferences
RSS

Preclinical cholesterol-lowering efficacy described for FR-194738

Oct. 16, 1997

Novel squalene synthase inhibitor reported by Pfizer

Oct. 15, 1997

Lenercept evaluated in phase II for sepsis/septic shock; development for RA halted

Oct. 15, 1997

New agent for restenosis reported by Taiho

Oct. 15, 1997

KRM-1648: a rifamycin derivative active against H. pylori and Mycobacterium spp.

Oct. 15, 1997

Echinocandin antifungal agent tested in patients

Oct. 15, 1997

Feasibility of OROS melatonin delivery evaluated in humans

Oct. 15, 1997

Sensus reports early clinical results with B2036-PEG

Oct. 15, 1997

Preliminary human evaluation of DMP-543, a potential antidementia agent

Oct. 15, 1997

Safety and pharmacokinetics of new hyperlipidemia Rx in humans

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...